Matches in Wikidata for { <http://www.wikidata.org/entity/Q64695472> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q64695472 description "clinical trial" @default.
- Q64695472 description "ensayu clínicu" @default.
- Q64695472 description "klinisch onderzoek" @default.
- Q64695472 description "клінічне випробування" @default.
- Q64695472 description "կլինիկական փորձարկում" @default.
- Q64695472 name "A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus" @default.
- Q64695472 type Item @default.
- Q64695472 label "A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus" @default.
- Q64695472 prefLabel "A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus" @default.
- Q64695472 P1132 Q64695472-AD351C3E-1C34-4238-8F9A-145BD8CB20D3 @default.
- Q64695472 P1476 Q64695472-4DA3BBE2-394C-4F0F-89BC-9E6668D17C3E @default.
- Q64695472 P17 Q64695472-1F4D93FC-A653-4BDE-A64E-5DA33F50DCB9 @default.
- Q64695472 P17 Q64695472-3A0150E9-2522-40A6-B9DC-7B9E2F33154F @default.
- Q64695472 P17 Q64695472-5388B3EF-AAD9-40CF-84E4-C1022FB4E4B4 @default.
- Q64695472 P17 Q64695472-9BBD45D5-FCB2-45A8-8F05-513250F970D5 @default.
- Q64695472 P17 Q64695472-A1A300B8-D64D-40D8-92FD-DEB0C189A6E9 @default.
- Q64695472 P2899 Q64695472-443B729C-7CA5-46BD-A191-70336731CA3C @default.
- Q64695472 P3098 Q64695472-BA3B9243-4234-426E-BD32-B0E30EA8DD25 @default.
- Q64695472 P31 Q64695472-15075D7E-B02C-4CF5-AD02-741AF023F385 @default.
- Q64695472 P4135 Q64695472-237FB79D-89E9-463F-AC4B-44EE06745D0D @default.
- Q64695472 P580 Q64695472-9FB09230-DFE8-42DE-8F6B-0C0688CB192D @default.
- Q64695472 P582 Q64695472-5EE639E9-7535-44DF-8CAB-DBA7E8B4EB78 @default.
- Q64695472 P6099 Q64695472-30EB158D-2D3A-4838-9205-802B194FD357 @default.
- Q64695472 P8363 Q64695472-03ABCE9F-04B6-48BA-BDD6-B88767C3D9FC @default.
- Q64695472 P1132 "+238" @default.
- Q64695472 P1476 "A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rontalizumab (rhuMAb IFNalpha) in Patients With Moderately to Severely Active Systemic Lupus Erythematosus" @default.
- Q64695472 P17 Q30 @default.
- Q64695472 P17 Q36 @default.
- Q64695472 P17 Q414 @default.
- Q64695472 P17 Q739 @default.
- Q64695472 P17 Q96 @default.
- Q64695472 P2899 "+18" @default.
- Q64695472 P3098 "NCT00962832" @default.
- Q64695472 P31 Q30612 @default.
- Q64695472 P4135 "+65" @default.
- Q64695472 P580 "2009-09-01T00:00:00Z" @default.
- Q64695472 P582 "2012-01-01T00:00:00Z" @default.
- Q64695472 P6099 Q42824440 @default.
- Q64695472 P8363 Q78089383 @default.